Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for EXPO and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for EXPO and 80,000+ other tickers.
See exactly how EXPO's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for EXPO and 80,000+ other tickers.
Exponent, Inc. functions as a global leader in scientific and engineering consulting, operating through its subsidiaries. The firm's activities are divided into two principal segments: Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific division offers a broad spectrum of services encompassing biomechanics, biomedical sciences, structural analysis, civil engineering, construction advisory, data analytics, electrical and computer science, human factors, materials and corrosion science, mechanical engineering, polymer chemistry, thermal dynamics…
Caisse de depot et placement du Quebec purchased a new stake in Exponent, Inc. (NASDAQ: EXPO) in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 20,200 shares of the business services provider's stock, valued at approximately $1,187,000. Several
Algert Global LLC decreased its position in Exponent, Inc. (NASDAQ: EXPO) by 69.8% during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 45,120 shares of the business services provider's stock after selling 104,110 shares during the period. Algert
Here is how Exponent (EXPO) and Gen Digital (GEN) have performed compared to their sector so far this year.
Newest addition to EXPO's portfolio features 2x larger tip* to help ideas stand out Key Summary: Designed for educators: EXPO XL helps teachers create bigger, bolder, more visible classroom content that can be read more easily from across the room. Built for maximum visibility: A double-width tip creates 2x larger lines than the best-selling EXPO Chisel marker, paired with EXPO's most vibrant ink formula.
The average of price targets set by Wall Street analysts indicates a potential upside of 25.7% in Exponent (EXPO). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.